Source-grounded facts extracted from Genasys Inc.'s SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
Genasys Inc. incurred term loan of $4.3 million with Maran Partners Fund, LP at 18% per annum maturing September 14, 2026.
“On June 9, 2026, Genasys Inc., a Delaware corporation (the “Company”), entered into a Loan Agreement (the “Loan Agreement”) with Maran Partners Fund, LP, a Delaware limited partnership (the “Lender”), pursuant to which the Lender extended an unsecured term loan to the Company in the principal amount of $4.3 million (the “Loan”).”
Genasys Inc. entered into Loan Agreement with Maran Partners Fund, LP valued at $4.3 million (effective 2026-06-09).
“On June 9, 2026, Genasys Inc., a Delaware corporation (the “Company”), entered into a Loan Agreement (the “Loan Agreement”) with Maran Partners Fund, LP, a Delaware limited partnership (the “Lender”), pursuant to which the Lender extended an unsecured term loan to the Company in the principal amount of $4.3 million (the “Loan”).”
Genasys Inc. amended Second Amendment to Term Loan and Security Agreement with Cantor Fitzgerald Securities valued at extension fee of 1.0% of the outstanding principal amount of the term loan (effective 2026-05-12).
“On May 12, 2026, Genasys Inc. (the “Company”) entered into a Second Amendment to Term Loan and Security Agreement (the “Amendment”) among the Company, Evertel Technologies, LLC, Zonehaven LLC, Genasys Puerto Rico, LLC, the lenders from time to time party thereto and Cantor Fitzgerald Securities, as administrative agent and collateral agent, which extended the maturity date for the term loan provided to the Company under that certain Term Loan and Security Agreement entered into among such parties on May 13, 2024 (as amended, the “Term Loan Agreement”) from May 13, 2026 to July 13, 2026, in exchange for an extension fee of 1.0% of the outstanding principal amount of the term loan.”
Genasys Inc. reported fiscal 2026 second quarter ended March 31, 2026 results: revenue $15.5 million, net income $0.7 million, EPS $0.02 basic and diluted.
“Protective Communications TM , today announced financial results for the Company’s fiscal 2026 second quarter ended March 31, 2026. Fiscal Q2 2026 Financial Summary • Revenue of $15.5 million, versus $6.9 million in the fiscal 2025 second quarter • Gross margin of 63.3%, versus 37.7% in the fiscal 2025 second quarter • GAAP operating income of $1.3 million, versus a”
Genasys Inc. amended term loan with Cantor Fitzgerald Securities maturing July 13, 2026.
“On May 12, 2026, Genasys Inc. (the "Company") entered into a Second Amendment to Term Loan and Security Agreement (the "Amendment") among the Company, Evertel Technologies, LLC, Zonehaven LLC, Genasys Puerto Rico, LLC, the lenders from time to time party thereto and Cantor Fitzgerald Securities, as administrative agent and collateral agent, which extended the maturity date for the term loan provided to the Company under that certain Term Loan and Security Agreement entered into among such parties on May 13, 2024 (as amended, the "Term Loan Agreement") from May 13, 2026 to July 13, 2026, in exchange for an extension fee of 1.0% of the outstanding principal amount of the term loan.”
Dennis D. Klahn retired as Chief Financial Officer at Genasys Inc..
“On May 13, 2025, Dennis D. Klahn, Chief Financial Officer of the Company, informed the Company that he intends to retire from all positions he holds with the Company and its subsidiaries during the fiscal fourth quarter of 2025.”
Mark Culhane was appointed as Director at Genasys Inc..
“On July 10, 2024, the Company announced the appointment of Mark Culhane to the Board of Directors”
Caltha Seymour resigned as Director at Genasys Inc..
“On July 1, 2024, Genasys Inc. (the “Company”) received notice from Caltha Seymour of her resignation from the Board of Directors of the Company effective immediately due to increasing demands of her employment.”
Scott L. Anchin resigned as Director at Genasys Inc..
“On May 20, 2024, the Company received written notice from Scott L. Anchin of his resignation from the Board of Directors of the Company (the “Board”), effective May 31, 2024, due to the requirements of his new employment.”
Genasys Inc. reported the fiscal quarter ended March 31, 2024 results: revenue $5.7 million, net income ($6.9) million, EPS ($0.16).
“of the software business rapidly growing. We are more confident in the long-term health of our business than we have ever been.” Fiscal 2Q 2024 Financial Summary ● Revenue of $5.7 million, versus $11.2 million in 2Q 2023 ● GAAP operating loss of ($6.9) million, versus ($3.4) million in 2Q 2023. ● GAAP net loss of ($6.9) million versus ($3.4) million in 2Q 2023.”
Genasys Inc. incurred term loan of $15,000,000 with Cantor Fitzgerald Securities at three-month SOFR plus five percent maturing May 13, 2026.
“On May 13, 2024, Genasys Inc. (the “Company”) entered into (a) a Term Loan and Security Agreement (the “Loan Agreement”) among the Company, Evertel Technologies, LLC (“Evertel”), Zonehaven LLC (“Zonehaven”), Genasys Puerto Rico, LLC (“Genasys PR”), the lenders from time to time party thereto (the “Lenders”) and Cantor Fitzgerald Securities, as administrative agent and collateral agent, pursuant to which the Company borrowed Fifteen Million Dollars ($15,000,000) (the “Loan Transaction”)”
Genasys Inc. entered into Right of First Refusal Agreement with Cantor Fitzgerald Securities valued at Right of first refusal on equity or debt financings during first year (effective 2024-05-13).
“the Company also entered into a Right of First Refusal Agreement (the “ROFR Agreement”), pursuant to which the Company granted to the Lenders a right of first refusal with respect to equity or debt financings completed by the Company during the first year following the closing of the Loan Transaction”
Genasys Inc. entered into Warrant Agreement with Cantor Fitzgerald Securities valued at Warrants to purchase up to 3,068,182 shares of common stock, exercise price $2.53 per share (effective 2024-05-13).
“(b) a Warrant Agreement (the “Warrant Agreement”) pursuant to which the Company agreed to issue to the Lenders warrants (the “Warrants”) to purchase up to 3,068,182 shares of the Company’s common stock at an initial exercise price of $2.53 per share”
Genasys Inc. entered into Term Loan and Security Agreement with Cantor Fitzgerald Securities valued at $15,000,000 borrowed, warrants to purchase up to 3,068,182 shares at $2.53 per share, interest SOFR+ (effective 2024-05-13).
“On May 13, 2024, Genasys Inc. (the “Company”) entered into (a) a Term Loan and Security Agreement (the “Loan Agreement”) among the Company, Evertel Technologies, LLC (“Evertel”), Zonehaven LLC (“Zonehaven”), Genasys Puerto Rico, LLC (“Genasys PR”), the lenders from time to time party thereto (the “Lenders”) and Cantor Fitzgerald Securities, as administrative agent and collateral agent, pursuant to which the Company borrowed Fifteen Million Dollars ($15,000,000) (the “Loan Transaction”)”
Craig Fugate was appointed as Director at Genasys Inc..
“the Company announced the appointment of Bill Dodd and Craig Fugate to the Board of Directors (the “Board”) of the Company effective June 1, 2024”
Bill Dodd was appointed as Director at Genasys Inc..
“the Company announced the appointment of Bill Dodd and Craig Fugate to the Board of Directors (the “Board”) of the Company effective June 1, 2024”
Genasys Inc. shareholders approved Advisory Vote on the Frequency of the Advisory Vote on the Compensation of our Named Executive Officers at the 2024-03-14 meeting.
“The stockholders, voted on an advisory, non-binding basis, that the frequency of the advisory vote on compensation of named executive officers should be as follows: One Year Two Years Three Years Abstain 14,803,597 78,673 457,599 1,122,390”
Genasys Inc. shareholders approved Advisory Vote on the Compensation of the Company's Named Executive Officers at the 2024-03-14 meeting.
“The compensation of the Company’s named executive officers as described in its Proxy Statement was approved, on an advisory, non-binding basis, by the following votes: For Against Abstain Broker Non-Votes 14,788,662 885,602 787,995 13,057,287”
Genasys Inc. shareholders approved Ratification of Independent Registered Public Accounting Firm at the 2024-03-14 meeting.
“The ratification of the appointment of Baker Tilly US, LLP as the Company’s independent registered public accounting firm for the fiscal year ended September 30, 2024, was approved by the following votes: For Against Abstain 27,834,270 1,494,188 191,088”
Genasys Inc. shareholders approved Election of Directors at the 2024-03-14 meeting.
“The five individuals listed below were elected at the 2024 Annual Meeting to serve for a one-year term on the Company’s Board of Directors: Number of Shares Number of Shares Nominee Voted For Withheld Broker Non-Votes Scott L. Anchin 15,638,261 823,998 13,057,287 Richard S. Danforth 15,552,916 909,343 13,057,287 Susan Lee 14,910,684 1,551,575 13,057,287 Richard H. Osgood III 15,690,383 771,876 13,057,287 Caltha Seymour 14,844,369 1,617,890 13,057,287”
Genasys Inc. reported fiscal first quarter ended December 31, 2023 results: revenue $4.4 million, net income ($6.7) million, EPS ($0.15) per share. Guidance reaffirmed.
“Fiscal 1Q 2024 Financial Summary ● Revenue of $4.4 million, versus $10.5 million in 1Q 2023 ● GAAP operating loss of ($7.2) million, versus ($3.5) million in 1Q 2023. ● GAAP net loss of ($6.7) million versus ($3.5) million in 1Q 2023. GAAP net loss per share ($0.15) versus ($0.10) in 1Q 2023.”
Genasys Inc. reported the fiscal first quarter ended December 31, 2023 results: revenue $4.4 million, net income ($6.7) million, EPS ($0.15).
“continues to displace incumbents and win the business that is already generating a rapidly growing Annual Recurring Revenue (ARR).” Fiscal 1Q 2024 Financial Summary ● Revenue of $4.4 million, versus $10.5 million in 1Q 2023 ● GAAP operating loss of ($7.2) million, versus ($3.5) million in 1Q 2023. ● GAAP net loss of ($6.7) million versus ($3.5) million in 1Q 2023.”
Genasys Inc. reported the fiscal fourth quarter ended September 30, 2023 results: revenue $10.7 million, net income ($10.1) million, EPS ($0.27).
“Revenue of $10.7 million, versus $16.0 million in 4Q 2022”
Genasys Inc. reported the fiscal year ended September 30, 2023 results: revenue $46.7 million, net income ($18.4) million, EPS ($0.50). Guidance raised.
“net loss of ($2.7) million vs. ($0.7) million in 4Q 2022. Adjusted net loss per share of ($0.07) vs. ($0.02) per share in 4Q 2022 Fiscal 2023 Financial Summary ● Revenue of $46.7 million, versus $54.0 million in fiscal 2022 ● GAAP operating loss of ($11.0) million, versus ($15.5) million in fiscal 2022. ● Adjusted EBITDA of ($6.8) million, versus $2.4 million in”
Genasys Inc. entered into Underwriting Agreement with Roth Capital Partners, LLC (effective 2023-09-28).
“On September 28, 2023, Genasys Inc. (the “Company”) entered into an Underwriting Agreement (the “Underwriting Agreement”) with Roth Capital Partners, LLC as representative of the several underwriters named therein, relating to the issuance and sale of common stock of the Company (the “Offering”).”
Genasys Inc. entered into Membership Interest Purchase Agreement with Word Systems Operations, LLC valued at approximately $5.8 million (effective 2023-09-20).
“On September 20, 2023, Genasys Inc., a Delaware corporation (the “Company”), Word Systems Operations, LLC, an Indiana limited liability company (“Seller”), and Evertel Technologies, LLC, a Nevada limited liability company (“Evertel”), entered into a Membership Interest Purchase Agreement (the “Purchase Agreement”), pursuant to which the Company agreed, upon the terms and subject to the conditions of the Purchase Agreement, to purchaser all of the Seller’s right, title and interest in, to and under all of the membership interests of Evertel”
Genasys Inc. reported financial results for fiscal third quarter ended June 30, 2023.
“On August 10, 2023, the Company issued a press release regarding its financial results for the fiscal third quarter ended June 30, 2023. A copy of the press release is furnished as Exhibit 99.1 hereto, and is incorporated by reference herein.”
Genasys Inc. reported Fiscal second quarter ended March 31, 2023 results: revenue $11.2 million, net income ($3.4 million), EPS ($0.09). Guidance lowered.
“Fiscal Second quarter revenue was $11.2 million, a decrease of 14.8% from $13.2 million in the prior year's quarter. Software revenue increased 26.7% and hardware revenue decreased 17.1%, compared with the fiscal 2022 second quarter. Gross profit margin was 43.9%, compared with 54.5% in the second quarter of fiscal 2022. As was the case in the first fiscal quarter, margins were negatively impacted by relatively higher component costs incurred to fulfill orders that were booked and priced prior to notification of higher supplier pricing. Operating expenses were $8.3 million, compared with $7.7 million in the same period a year ago. Selling, general and administrative expenses increased 4.2% from $5.8 million in the prior year to $6.1 million in the quarter ended March 31, 2023. Research and development expenses increased 20.5% year-over-year from the addition of 5% more engineers over the prior year to increase the features and functionality of our software offerings. GAAP net loss in t”
Genasys Inc. shareholders approved Advisory Vote on the Compensation of the Company’s Named Executive Officers at the 2023-03-14 meeting.
“Advisory Vote on the Compensation of the Company ’ s Named Executive Officers : The compensation of the Company’s named executive officers as described in its Proxy Statement was approved, on an advisory, non-binding basis, by the following votes:”
Genasys Inc. shareholders approved Ratification of Independent Registered Public Accounting Firm at the 2023-03-14 meeting.
“Ratification of Independent Registered Public Accounting Firm : The ratification of the appointment of Baker Tilly US, LLP as the Company’s independent registered public accounting firm for the fiscal year ended September 30, 2023, was approved by the following votes:”
Genasys Inc. shareholders approved Election of Directors at the 2023-03-14 meeting.
“Election of Directors : The five individuals listed below were elected at the 2023 Annual Meeting to serve for a one-year term on the Company’s Board of Directors:”
Genasys Inc. reported fiscal first quarter ended December 31, 2022 results: revenue $10.5 million, net income $3.5 million, or ($0.10) per share, EPS ($0.04) per share. Guidance reaffirmed.
“by hardware orders, as well as a developing pipeline of SaaS opportunities." Mr. Danforth added, "In what is typically our slowest quarter, fiscal first quarter revenue was $10.5 million, in-line with our expectations. As per our usual pattern, we anticipate sequential quarterly revenue to increase in the fiscal second quarter and then strengthen in the fiscal”
Genasys Inc. reported the fiscal fourth quarter ended September 30, 2022 results: revenue $16.0 million, net income $13.8 million, EPS $0.38 per share.
“and business model ● Integrated Mass Notification System revenue grew 457% Fourth Quarter and Fiscal Year 2022 Financial Updates ● Fourth quarter revenue increased by 7% to $16.0 million, and fiscal year 2022 revenue increased by 15% to $54.0 million ● Fiscal fourth quarter bookings were $6.0 million, bringing total bookings for fiscal 2022 to $38.2 million. From”
Genasys Inc. reported the fiscal year ended September 30, 2022 results: revenue $54.0 million, net income $16.2 million, EPS $0.44 per share.
“--- EX-99.1 3 ex_451680.htm EXHIBIT 99.1 ex_451680.htm Exhibit 99.1 Genasys Inc. Reports Fiscal Fourth Quarter and Full Year 2022 Financial Results Annual Revenue Up 15% to $54.0 Million SaaS Platform Gaining Momentum on Strategic Investments SAN DIEGO, CA – November 30, 2022 – Genasys Inc. (NASDAQ: GNSS), the global leader in critical communications systems and”
Laura M. Clague retired as Director at Genasys Inc..
“On May 6, 2022, the Company received notice from Laura M. Clague of her retirement from the Board of Directors of Genasys Inc. (the "Company") effective June 30, 2022.”
Daniel H. McCollum was appointed as Strategic Advisory Board at Genasys Inc..
“Concurrent with his resignation from the Company’s Board, Mr. McCollum and the Company entered into a Board Adviser Agreement (the “Adviser Agreement”), which is effective as of Mr. McCollum’s resignation. Pursuant to the Adviser Agreement, Mr. McCollum will join the Company’s Strategic Advisory Board”
Daniel H. McCollum resigned as Director at Genasys Inc..
“On November 11, 2021, the Company received written notice from Daniel H. McCollum of his resignation from the Board of Directors of the Company (the “Board”) and from all Board committees on which he serves.”
John G. Coburn was appointed as Chair of the Strategic Advisory Board at Genasys Inc..
“Pursuant to the Adviser Agreement, General Coburn will become the Chair of the Company’s Strategic Advisory Board.”
John G. Coburn resigned as Chairman of the Board at Genasys Inc..
“On October 22, 2021, the Company received written notice from General John G. Coburn of his resignation from the Board of Directors of the Company (the “Board”), effective November 1, 2021.”
Caltha Seymour was appointed as Director at Genasys Inc..
“On August 18, 2021, Genasys Inc. (the “Company”) announced the appointment of Susan Lee and Caltha Seymour to the Board of Directors (the “Board”) of the Company effective September 1, 2021”
Susan Lee was appointed as Director at Genasys Inc..
“On August 18, 2021, Genasys Inc. (the “Company”) announced the appointment of Susan Lee and Caltha Seymour to the Board of Directors (the “Board”) of the Company effective September 1, 2021”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.